Anticoagulation in 2016: Concepts of Care for Community-based Pharmacists

From: April 23, 2016
To: April 23, 2016

Location: 
Bernard Snell Hall, University of Alberta
8440 112 Street, Edmonton, AB

Time: 8:00 a.m. – 1:00 p.m.

Conference Brochure 

Register at www.eply.com/CLOTWorkshop2016

Deadline is April 14, 2016 *there will be NO onsite registration*

Community pharmacists are known as being one of the most accessible healthcare professionals. Throughout Canada, pharmacists’ scope of practice has evolved, and most now play a proactive role in managing medications. Anticoagulation management is a good example of this evolution with more community pharmacist involved in both monitoring and managing anticoagulation care. Much has changed over the past decade. Warfarin and low molecular weight heparins still have a place in care for many patients, and several novel oral anticoagulants (NOACs) are now available for use in the prevention of stroke for atrial fibrillation (AF) and the acute treatment/prevention of recurrent venous thromboembolism (VTE). With the plethora of data, community pharmacists are well situated to ensure appropriate selection and ongoing monitoring of these agents.

This learning event will utilize case vignettes to provide up to date information on anticoagulation therapies covering common thrombosis topics relevant to community pharmacy practice.

Learning Objectives

At the end of this session the learner will:

  • More effectively assess appropriateness of prescriptions for anticoagulation therapies including agent selection and dose implemented.
  • Understand concepts of anticoagulation management in atrial fibrillation and venous thromboembolism.
  • Gain an awareness of drug interactions, and insight into ongoing monitoring and follow-up.
  • Assess a patient’s risk of thrombosis versus risk of bleeding, and educate patients on signs and symptoms of bleeding and clotting as a patient monitoring strategy.
  • Understand anticoagulation treatment gaps, therapy interruptions, and considerations for rural vs urban practice.
  • Discuss strategies to improve patient adherence to anticoagulation therapy.
  • Have access to available anticoagulation related clinician and patient support resources.

About the Collaborative Learning on Thrombosis (CLOT)

The Collaborative Learning on Thrombosis (CLOT) group consists of pharmacists from the Prairie Provinces (Alberta, Saskatchewan, and Manitoba) with an interest or practice in the management of thrombosis/anticoagulation therapies.  It provides a forum to network and gain expertise to facilitate knowledge transfer to other pharmacists and healthcare practitioners to optimize the care of patients with thromboembolic disease.